Drug class
Haemostatic agent; capillary-stabilising drug
Mechanism of action
Proposed to improve platelet adhesion and capillary endothelial stability and reduce capillary bleeding. The exact molecular mechanism and magnitude of clinical benefit are not fully established.
General use cases
- Used in some countries for prevention or reduction of capillary bleeding, including selected surgical or gynaecological bleeding indications; availability and evidence vary by jurisdiction and it should not replace definitive haemostatic treatment
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
